logo

North America Epigenetics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The North America Epigenetics Market is segmented By Product (Instruments, Reagents & Kits, Others), By Application, By Technology and Geography.

Home Industry Reports Healthcare North America Epigenetics Market - Growth, Trends, COVID-19 Impact, and Forecast ...

Market Snapshot

Market Snapshot
Study Period: 2018 - 2026
Base Year: 2020
CAGR: 20 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The North America Epigenetics Market is expected to register a 20% of CAGR growth during the forecast period. The key contributor to the market is the growing burden of cancer and increasing investments into research and development activities. 

According to the American Cancer Society, in 2020, around 1.8 million new cases will be diagnosed in the United States and about 606,520 people are expected to die due to it. Epigenetics modifications can influence the cellular responses with respect to the apoptosis, cell proliferation and senescence. 

Hence, epigenetics has a very crucial role in cancer treatment and thereby it is expected to boost the market growth over the forecast period.

Scope of the report

Epigenetics refers to the study of genetic controlling by factors except the DNA sequencing of an individual. It majorly deals with the gene expression. The North America Epigenetics Market is segmented By Product, By Application, By Technology and Geography.

By Product
Instruments
Reagents & Kits
Others
By Applications
Oncology
Autoimmune Diseases
Metabollic Diseases
CNS/Pain Diseases
Cardiovascular Diseases
Others
By Technology
Methylation
Acetylation
Phosphorylation
Others
By Geography
North America
United States
Canada
Mexico

Report scope can be customized per your requirements. Click here.

Key Market Trends

Cardiovascular Diseases are Expected to Show a Steady Growth in the North America Epigenetics Market

Cardiovascular diseases are expected to show steady growth in the market during the forecast period. Recent studies have shown that epigenetics has a very significant role in cardiovascular diseases. The information of epigenetics can help in determining the response of an individual towards the drug. In addition, it can also be developed to assess the risk determinants for cardiovascular diseases. Hence, it can be a diagnosis and prognosis of cardiovascular diseases. Heart diseases are one of the leading cause of death in the United States. As per the Centre for Disease Control and Prevention, one person dies in every 37 seconds in America due to cardiovascular disease. 

Furthermore, the increasing investments into R&D are expected to impact positively on the market. According to the Pharmaceutical Research and Manufacturers of America (PhRMA), 2018, around USD 79.6 billion were spent on the research and development activities. Thus, the aforementioned factors are expected to impact positively on the market in this segment.

Cell Surface Markers Detection Trend Image.png

To understand key trends, Download Sample Report

Competitive Landscape

The key players in the North America Epigenetics market are Abcam PLC, Active Motiff, Diagenode Inc., F. Hoffmann-La Roche Ltd, Illumina Inc., Qiagen N.V., Merck & Co. Inc., ThermoFisher Scientific and Zyhmo Research Corporation.

NA Epigentics Market Concentration.png

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Burden of Cancer Diseases

      2. 4.2.2 Increasing Investments into Research and Development Activities

      3. 4.2.3 Rising Epigenetic Applications in Non-oncology Diseases

    3. 4.3 Market Restraints

      1. 4.3.1 Presence of Stringent Regulatory Framework

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 Instruments

      2. 5.1.2 Reagents & Kits

      3. 5.1.3 Others

    2. 5.2 By Applications

      1. 5.2.1 Oncology

      2. 5.2.2 Autoimmune Diseases

      3. 5.2.3 Metabollic Diseases

      4. 5.2.4 CNS/Pain Diseases

      5. 5.2.5 Cardiovascular Diseases

      6. 5.2.6 Others

    3. 5.3 By Technology

      1. 5.3.1 Methylation

      2. 5.3.2 Acetylation

      3. 5.3.3 Phosphorylation

      4. 5.3.4 Others

    4. 5.4 By Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abcam PLC

      2. 6.1.2 Active Motiff

      3. 6.1.3 Diagenode Inc.

      4. 6.1.4 F. Hoffmann-La Roche Ltd

      5. 6.1.5 Illumina Inc.

      6. 6.1.6 Qiagen N.V.

      7. 6.1.7 Merck KGaA

      8. 6.1.8 TherFisher Scientific

      9. 6.1.9 Zyhmo Research Corporation

      2. *List Not Exhaustive

  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The North America Epigenetics Market market is studied from 2018 - 2026.

The North America Epigenetics Market is growing at a CAGR of 20% over the next 5 years.

Diagenode Inc., Merck KGaA, Illumina Inc., Active Motiff, Abcam Plc are the major companies operating in North America Epigenetics Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!